Accredited Symposia

Location: The Westin Resort & Spa, Whistler – Alpine ABCD

Accredited Symposia will be held each morning at breakfast and on Tuesday at lunch. They are open to all delegates but seating is limited.

The Patient’s Journey in Hidradenitis Suppurativa (HS)

Hidradenitis Suppurativa (HS) is a debilitating chronic and painful inflammatory disease associated with a number of concomitant comorbidities. The diagnosis of HS is often overlooked by physicians, so there may be more common than is recognized.  Early disease recognition is critical for reducing the impact on patients’ life. Emergency physicians can improve outcomes through rapid referral strategy to dermatologists.

Please join Dr. James McGorman and Dr. Alain Brassard and learn more on patient-centred solutions that will bring hope and new beginnings to the journey of people living with HS.

SPEAKERS:  Dr. Alain Brassard, Dermatologist from Edmonton,  and Dr. James McGorman, ER Physician from Peterborough.

GENERAL EDUCATIONAL OBJECTIVES

By attending the symposium, the participant will review:

  • How to improve the recognition of the disease at the Emergency Department (ED) level,
  • The burden of the patient journey and the impact on the patient’s live, and
  • Why quick referral to Dermatology will offer the best management plan for those patients living with the disease.

Improving the diagnosis and management of angioedema in the ED

Dr. Jacques Hébert, Dr. John Hollingsworth

Chair: Dr. Andrew MacPherson

Learning Objectives:

  1. Increase awareness and understanding of the various types of angioedema
  2. Examine the critical role of bradykinin and histamine as key mediators in angioedema
  3. Determine the most appropriate treatment for angioedema patients during an acute attack
  4. Discuss patient referral to an allergist or immunologist

Recent Advances in ED Management of Acute Atrial Fibrillation

LEARNING OBJECTIVES

Regarding acute atrial fibrillation in the ED, we will:

  1. Review current Canadian Guidelines for ED management of AAF
  2. Review when it is safe and not safe to cardiovert in the ED
  3. Discuss the CHADS-65 algorithm for stroke prevention
  4. Discuss new therapeutic options for cardioversion

DESCRIPTION

Dr. Ian Stiell, Professor of Emergency Medicine at U Ottawa, will review the recently updated CCS guidelines for AAF management in the ED with a focus on safe cardioversion, stroke prevention, and an interesting new therapeutic option for rapid pharmacological cardioversion.

Bird on the Wire: Managing the Clot and Bleed Challenge for AF & VTE Patients

Dr. Anas Nseir, Dr. Eddy Lang and Dr. Indraneel Ghosh

Program Description:

Bird on the Wire: Managing the Clot and Bleed Challenge for AF & VTE Patients

is an interactive case-based program aimed at emergency department (ED) physicians that shines a spotlight on the treatment and management of atrial fibrillation (AF) and venous thromboembolism (VTE) in patients in an ED setting.

Complex clinical cases will be used to provide the most up-to-date, evidence-based data on how to safely and effectively treat patients on direct oral anticoagulants (DOAC), whether they are experiencing AF or VTE. What’s more, this program will explore when and how to initiate and optimize treatment in special patient populations through common and challenging cases.

Learning Objectives:

After attending this symposium, you will be able to:

  1. Initiate treatment of atrial fibrillation (AF) when appropriate in common and challenging cases.
  2. Apply an algorithmic, evidence-based approach to the management of patients on direct oral anticoagulants (DOACs).
  3. Integrate the most up-to-date and EM-relevant guidelines for atrial fibrillation (AF) and venous thromboembolism (VTE) into your practice.